Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meclizine vs Dimenhydrinate in Acute Peripheral Vertigo
NCT02112578Phase 3Completed
- Sponsor
- Apsen Farmacêutica
- Start
- Nov 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of meclizine in Peripheral vertigo, sponsored by Apsen Farmacêutica. Started Nov 2016; status: completed.
02
Drugs
meclizine
03
Conditions
Peripheral vertigo
Beyond the preview
Go deeper on NCT02112578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112578.